Back

Higher inflammatory cytokines in long-covid with cardiovascular symptoms after acute severe COVID-19? A two-year, pre-vaccine, longitudinal, exploratory, nested cohort.

25 April 2024 (14:48 - 15:00)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award - Primary Care & Risk Factor Management Cardiovascular Risk Assessment Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Cassia Luz Goulart

Hospital de Clínicas de Porto Alegre, Porto Alegre (Brazil)

4 More presentations in this session

Presentation thumbnail
Early insulin resistance in low-risk subjects with normal glycemia is associated with subclinical atherosclerosis
Doctor J. Iglesies-Grau (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Development, validation and prospective clinical implementation of a machine learning algorithm for incident cardio-renal-metabolic diseases and cardiovascular death: the OPTIMISE study.
Doctor R. Nadarajah (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Cholesterol paradox in atrial fibrillation: is it solved in lipid-lowering drugs users?
Doctor B. Bartos (Olsztyn, PL)
Abstract Slides Video
Presentation thumbnail
Comparative effectiveness of non-pharmacological interventions on metabolic syndrome and its components: a systematic review and network meta-analysis
Ms B. Chan (Hong Kong, HK)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award - Primary Care & Risk Factor Management

The Event

Event poster

ESC Preventive Cardiology 2024

25 April 2024 14:48 CET
You may be interested in
thumbnail
Congress Presentation
Multimodality imaging and immunophenotyping of COVID-19 related myocardial injury (the MIIC-MI Study)
thumbnail
Congress Presentation
Prognostic role of advanced cardiac imaging in assessing myocardial injury and its correlation with biomarkers in young patients recovering from COVID 19
thumbnail
Congress Presentation
Serum proteomic profiling reveals potential inflammatory biomarkers in long-COVID patients: a comparative analysis with healthy controls

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources